ESLAW
NASDAQ
$0.13
Estrella Immunopharma Inc - Warrants (29/09/2028) (ESLAW)
Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company is headquartered in EmeryVille, California.
This company is also listed under the following ticker: ESLA.
Website: https://www.estrellabio.comBeta (5Y)
0.20
Price Chart
Growth & Risk
Beta (5Y)0.20
Sharpe Ratio1.45